AGENNIX AG has a total of 11 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AMAKEM NV, EOLAS THERAPEUTICS INC and HIMMELSBACH FRANK.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Kluge Arthur F | 7 |
#2 | Petrak Karel | 2 |
#3 | Varadhachary Atul | 2 |
#4 | Obermayr Franz | 1 |
#5 | Ivanov Igor | 1 |
#6 | Schuhmacher Marino | 1 |
#7 | Wosikowski-Buters Katja | 1 |
#8 | Schaab Christoph | 1 |
Publication | Filing date | Title |
---|---|---|
EP2416800A1 | Oral lactoferrin in the treatment of severe sepsis |